Oisin Biotechnologies is focused on creating drugs to combat a variety of age-related diseases. Founded by Garry Hudson and Matthew Scholz in 2014, Oisin Biotechnologies is backed by investors that include Hedgewood, Avant Global, Kingsley Advani, KIZOO Technology Capital, Althea Group Ventures and is headquartered in Seattle.
FOUNDED:
2014
INDUSTRY:
Biopharma, Biotechnology, Medical
FOUNDERS:
Garry Hudson, Matthew Scholz
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
